PMVP PMV Pharmaceuticals, Inc.
1.500USD-6.83%Mkt Cap: 113.27M $P/E: —1d ago
PMV Pharmaceuticals, Inc., a precision oncology company, engages in the discovery and development of small molecule therapies targeting p53 mutations and other p53-related cancers in the United States. It develops rezata…
Industry Peers
BiotechnologyKey Statistics
Company
Market Cap113.27M USD
Enterprise Value6.85M USD
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-77.74M USD
Revenue/Share—
Last Price1.500 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees54
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-1.67
PEG—
EV/EBITDA-0.09
EV/Revenue—
P/S—
P/B1.20
EPS (TTM)-1.30
EPS (Forward)-0.97
52W Range
1.02054% of range1.910
52W High1.910 USD
52W Low1.020 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-74.24%
ROA-66.70%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-73.58M USD
CapEx (TTM)29.00K USD
FCF Margin—
FCF Yield-38.69%
Net Debt-79.21M USD
Net Debt/EBITDA1.00
Balance Sheet
Debt/Equity0.01
Current Ratio7.70
Quick Ratio7.52
Book Value/Sh1.34 USD
Cash/Share1.49 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)4.200 USD
Upside (mean)+180.0%
Target Range3.000 USD – 5.000 USD
3.000+180.0% to mean5.000
# Analysts5
Ownership
Shares Out.75.51M
Float43.29M
Insiders2.37%
Institutions46.43%
Short Interest
Short Ratio3.8d
Short % Float3.96%
Short % Out.3.87%
Shares Short2.92M
Short (prev mo.)2.24M
Technical
SMA 501.326 (+13.1%)
SMA 2001.288 (+16.5%)
Beta1.35
S&P 52W Chg16.45%
Avg Vol (30d)974.95K
Avg Vol (10d)1.22M
Technical Indicators
RSI (14)52.1
MACD0.0932
MACD Signal0.0808
MACD Hist.+0.0124
BB Upper1.796 USD
BB Middle1.480 USD
BB Lower1.164 USD
BB Width42.77%
ATR (14)0.1338 USD
Vol Ratio (20d)0.61x